Literature DB >> 21955625

Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

N Pavan Kumar1, R Anuradha, R Suresh, R Ganesh, Janani Shankar, V Kumaraswami, Thomas B Nutman, Subash Babu.   

Abstract

Type 1 cytokine responses are known to play an important role in immunity to tuberculosis (TB) in children, although little is known about other factors that might be important. In addition, children are more prone to developing extrapulmonary manifestations of TB than adults. To identify the immune responses important both in control of infection and in extrapulmonary dissemination, we examined mycobacterium-specific cytokine responses of children with pulmonary TB (PTB) and extrapulmonary TB (ETB) and compared them with those of healthy control children (HC). No significant differences were found in the cytokine responses either with no stimulation or following mycobacterial-antigen (Ag) stimulation between children with PTB and ETB. On the other hand, children with active TB compared with HC showed markedly diminished production of type 1 (gamma interferon [IFN-γ] and tumor necrosis factor alpha [TNF-α]), 2 (interleukin 4 [IL-4] and IL-13), and 17 (IL-17A, IL-21, and IL-23)-associated cytokines with no stimulation and in response to mycobacterial antigens. This was not associated with significantly altered production of IL-10 or transforming growth factor β (TGF-β). Among children with ETB, those with neurologic involvement exhibited more significantly diminished Ag-driven IFN-γ and IL-17 production. Pediatric TB is characterized by diminished type 1, 2, and 17 cytokine responses, with the most profound diminution favoring development of neurologic TB, suggesting a crucial role for these cytokines in protection against pediatric tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955625      PMCID: PMC3209030          DOI: 10.1128/CVI.05366-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  43 in total

Review 1.  Childhood tuberculosis: an emerging and previously neglected problem.

Authors:  Ben J Marais; H Simon Schaaf
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

2.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

3.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Authors:  V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

4.  Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells.

Authors:  Xinchun Chen; Mingxia Zhang; Mingfeng Liao; Michael W Graner; Changyou Wu; Qianting Yang; Haiying Liu; Boping Zhou
Journal:  Am J Respir Crit Care Med       Date:  2009-12-17       Impact factor: 21.405

Review 5.  Global epidemiology of paediatric tuberculosis.

Authors:  Tony Walls; Delane Shingadia
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

Review 6.  Global epidemiology of childhood tuberculosis.

Authors:  L J Nelson; C D Wells
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

7.  Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.

Authors:  Steven M Holland
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 8.  Th2 cytokines in susceptibility to tuberculosis.

Authors:  Graham A W Rook
Journal:  Curr Mol Med       Date:  2007-05       Impact factor: 2.222

Review 9.  Immunity to tuberculosis.

Authors:  Robert J North; Yu-Jin Jung
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  Characteristics and programme-defined treatment outcomes among childhood tuberculosis (TB) patients under the national TB programme in Delhi.

Authors:  Srinath Satyanarayana; Roopa Shivashankar; Ram Pal Vashist; Lakhbir Singh Chauhan; Sarabjit Singh Chadha; Puneet Kumar Dewan; Fraser Wares; Suvanand Sahu; Varinder Singh; Nevin Charles Wilson; Anthony David Harries
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

View more
  16 in total

1.  Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia.

Authors:  W van Loon; M P Gomez; D Jobe; K L M C Franken; T H M Ottenhoff; M Coninx; L Kestens; J S Sutherland; B Kampmann; L D Tientcheu
Journal:  BMC Infect Dis       Date:  2020-07-02       Impact factor: 3.090

Review 2.  Advances in Drug Discovery and Development for Pediatric Tuberculosis.

Authors:  Daniel Hoagland; Ying Zhao; Richard E Lee
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

3.  Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.

Authors:  R C Chukwuanukwu; C C Onyenekwe; L Martinez-Pomares; R Flynn; S Singh; G I Amilo; N R Agbakoba; J O Okoye
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

4.  Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection.

Authors:  Anuradha Bandaru; Kamakshi P Devalraju; Padmaja Paidipally; Rohan Dhiman; Sambasivan Venkatasubramanian; Peter F Barnes; Ramakrishna Vankayalapati; Vijayalakshmi Valluri
Journal:  Eur J Immunol       Date:  2014-04-23       Impact factor: 5.532

5.  Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children.

Authors:  Magdalena Druszczynska; Michal Seweryn; Sebastian Wawrocki; Magdalena Kowalewska-Pietrzak; Anna Pankowska; Wieslawa Rudnicka
Journal:  Pathogens       Date:  2021-04-24

6.  Evaluation of Interleukin17and Interleukin 23 expression in patients with active and latent tuberculosis infection.

Authors:  Fatemeh Heidarnezhad; Amir Asnaashari; Seyed Abdolrahim Rezaee; Roghayeh Ghezelsofla; Kiarash Ghazvini; Narges Valizadeh; Reza Basiri; Aghigh Ziaeemehr; Somayeh Sobhani; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2016-08       Impact factor: 2.699

7.  Disseminated Tuberculosis and Chronic Mucocutaneous Candidiasis in a Patient with a Gain-of-Function Mutation in Signal Transduction and Activator of Transcription 1.

Authors:  Sigifredo Pedraza-Sánchez; Jose Luis Lezana-Fernández; Yolanda Gonzalez; Luis Martínez-Robles; María Laura Ventura-Ayala; Stanislaw Sadowinski-Pine; Margarita Nava-Frías; Sarbelio Moreno-Espinosa; Jean-Laurent Casanova; Anne Puel; Stephanie Boisson-Dupuis; Martha Torres
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

8.  Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patients.

Authors:  Katja Kleinsteuber; Kerrin Heesch; Stefanie Schattling; Malte Kohns; Claudia Sander-Jülch; Gerhard Walzl; Anneke Hesseling; Ertan Mayatepek; Bernhard Fleischer; Florian M Marx; Marc Jacobsen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras.

Authors:  Nancy Alvarez-Corrales; Raija K Ahmed; Carol A Rodriguez; Kithiganahalli N Balaji; Rebeca Rivera; Ramakrishna Sompallae; Nalini K Vudattu; Sven E Hoffner; Alimuddin Zumla; Lelany Pineda-Garcia; Markus Maeurer
Journal:  BMC Infect Dis       Date:  2013-03-06       Impact factor: 3.090

10.  Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins.

Authors:  Changyou Wu; Zitao Li; Xiaoying Fu; Sifei Yu; Suihua Lao; Binyan Yang
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.